Atrial fibrillation due to oral methylprednisolone in a patient with membranoproliferative glomerulonephritis.
Cardiac adverse effects of intravenous pulse methylprednisolone administration are well known, but there is little information about the cardiac side effects of oral methylprednisolone in the literature. We present a 41 year-old man with membranoproliferative glomerulonephritis in whom developed atrial fibrillation after oral methylprednisolone therapy.
Dogukan
Ayhan
A
Department of Nephrology, Firat University, Faculty of Medicine, Elazig, Turkey. aydogukan@hotmail.com
Ilkay
Erdogan
E
Poyrazoglu
Orhan K
OK
Gunal
Ali Ihsan
AI
Ozgen
Metin
M
Pekdemir
Murat
M
D000284:Administration, Oral; D000328:Adult; D001281:Atrial Fibrillation / Q000139:chemically induced*; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*
D005938:Glucocorticoids; D008775:Methylprednisolone